Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shogo Fujita is active.

Publication


Featured researches published by Shogo Fujita.


Artificial Cells, Blood Substitutes, and Biotechnology | 1997

NEO RED CELL AS AN ORGAN PRESERVATION SOLUTION

Y. Funakoshi; Shogo Fujita; S Fuchinoue; T Agishi; Ota K

Neo red cell (NRC) was derived from outdated human red cells. The following experimental work has been done in order to investigate if NRC is valid for organ preservation. Hearts were obtained from male Lewis rat (250-350 g body weight). Heart transplantation was performed as Ono-Lindseys method after 1, 3, 6, 12 and 24 hours simple cold storage. Rats were divided into two groups. Group 1; original NRC as preservation solution, Group 2; modified NRC (NRC suspended with UW solution) as preservation solution. After 1, 3, and 6 hour cold ischemic storage, the transplanted hearts in both groups showed contraction immediately after declamping the aorta and the pulmonary artery. After 12 and 24 hour preservation, the transplanted hearts in group 2 showed contraction. Myocardial ATP levels after 6, 12, 24 hours cold storage compared with 0 hour were 62.3%, 28.3%, 32.8% in group 1 respectively. On the contrary, myocardial ATP levels were 87.2%, 57.6%, 52.2% in group 2 respectively. After 24 hour preservation, pathological change was not remarkable between the two groups. Results of the prolonged preservation time and the myocardial ATP changes suggest that there is a possibility for effective use of NRC not only as blood substitute but also organ preservation solution.


Diabetes | 1989

Modulation of Prostaglandin Metabolism by K-MAP and Prevention of Toxic Effect of Cyclosporin on Pancreatic Islet Cells

S. Teraoka; Tatsuo Kawai; Tetsuya Babazono; Shohei Fuchinoue; Hiroshi Honda; Ichiro Nakajima; Hiroyasu Fujikawa; Taketoshi Hayashi; Yoshihiko Nakagawa; Shogo Fujita; Tojinbara T; Ota K

The injection of 25 mg/kg i.p. cyclosporin (CsA) for 3 wk caused marked functional and morphological deteriorations of pancreatic islet cells in Wistar rats that were prevented by the combined administration of p-aminobenzoic acid-N-D-mannoside sodium salt (K-MAP). In this article, the toxic effect of CsA on pancreatic islet cells and the preventive effect of K-MAP on CsA-associated islet cell toxicity were investigated. Prolonged hyperglycemia and depressed insulin secretion after the glucose challenge observed in CsA-treated rats could be prevented by the combined administration of 300 and 900 mg/kg K-MAP. Cytoplasmic vacuolizations and a decrease in the number of mitochondria, intact endoplasmic reticula, secretory granules, and insulin-positive cells, as revealed by peroxidase-antiperoxidase staining, could also be prevented by the administration of 900 mg/kg K-MAP. This preventive effect of K-MAP on CsA-associated islet cell toxicity may suggest the combined use of K-MAP with CsA in pancreas transplantation and treatment of insulin-dependent diabetes.


Artificial Cells, Blood Substitutes, and Biotechnology | 1992

Evaluation of a Pyridoxylated Hemoglobin Polyoxyethylene Conjugate Solution as a Perfusate for Small Intestine Preservation

H. Liu; T Agishi; Tatsuo Kawai; Taketoshi Hayashi; Shogo Fujita; S Fuchinoue; Kota Takahashi; S. Teraoka; Ota K

A new type of artificial blood, pyridoxylated hemoglobin-polyoxyethylene conjugate (PHP) solution, (developed by PHP research group of the department of health and welfare of Japan, and produced by Ajinomoto Co., Inc. Tokyo) as an oxygen-carrying component, has been recently devised using hemoglobin obtained from hemolyzed human erythrocytes. Recently, the studies using this solution as a preservation solution were performed in some instances. To examine the mechanism of improved viability using this solution as a preservation solution, we developed a model of orthotopic small intestine transplantation (OIT) in the rat. As a baseline study, we compared parameters of viability of the grafts preserved in Collins and UW solution to those preserved in PHP solution including a survival rate, a serum level total protein and albumin, and a change in body weight after transplantation. In our study, the simple hypothermia storage together with intestinal perfusion preservation with PHP solution was performed. Animals were divided into 6, 12, and 24 hr preservation groups. All of the rats survived after 6 hr preservation following transplantation. However, in 12 hr storage, five of six rats in PHP solution preservation survived and recovery in body weight after grafting was better than those with Collins and UW solution. We conclude that the PHP solution is, therefore, considered to possibly be a more suitable perfusate for small intestine preservation than Collins and UW solution.


International congress on pancreatic and islet cell transplantation. 2 | 1990

Mechanism of the preventive effect of aminobenzoic acid salt on pancreatic islet B cell toxicity by cyclosporine.

S. Teraoka; Tatsuo Kawai; Yamaguchi Y; Shogo Fujita; S. Tojinbara; T. Nakajima; Taketoshi Hayashi; Yuki Nakagawa; Hiroyasu Fujikawa; Hiroshi Honda; S Fuchinoue; Ota K; M. Togawa; Y. Ishida; M. Ikuzawa; S. Nakajima


Transplantation proceedings | 1989

Cyclosporine-associated toxicity in pancreatic islet cells and its prevention by K-MAP in cyclosporine-treated animals.

S. Teraoka; Tatsuo Kawai; Yamaguchi Y; Tojinbara T; Shogo Fujita; Ichiro Nakajima; Yuki Nakagawa; Hiroyasu Fujikawa; Taketoshi Hayashi; Hiroshi Honda


Nihon Toseki Igakkai Zasshi | 1997

Clinical application of a new E-PTFE vascular graft for hemodialysis

Yoshihiko Nakagawa; Kazuo Ohta; Hiroaki Haruguchi; Yasuko Uchida; Tohru Murakami; Junichiro Sageshima; Hiroyuki Nishina; Tarou Koike; Masahiro Abe; Sachiko Hirotani; Youichi Funakoshi; Shogo Fujita; Tatsuo Kawai; Shohei Fuchinoue; Satoshi Teraoka; Tetsuzo Agishi


Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2005

A CASE OF LAPAROSCOPIC FENESTRATION FOR LYMPHOCELE AFTER RENAL TRANSPLANTATION

Junichi Taka; Osamu Yoshitake; Shogo Fujita; Masahiko Murakami; Mitsuo Kusano


Transplantation proceedings | 1996

Prevention of hyperacute xenograft rejection by polyclonal antibodies against donor blood cells.

Shogo Fujita; Yutaro Hayasaka; Toru Murakami; Shinkai M; Tatsuo Kawai; S Fuchinoue; S. Teraoka; T Agishi; Ota K


Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 1991

PATENCY AND COMPLICATIONS AFTER IMPLANTATION OF VASCULAR ACCESS DEVICE

Taketoshi Hayashi; Tetsuzo Agishi; Hiroshi Honda; Shogo Fujita; T Tojimbara; Tatsuo Kawai; Shohei Fuchinoue; S. Teraoka; Kazuo Ota


International congress of the transplantation society | 1991

The changes in prostaglandins after segmental pancreatic transplantation

Tatsuo Kawai; S. Teraoka; Taketoshi Hayashi; S Fuchinoue; Hiroshi Honda; Ichiro Nakajima; H. Suga; Shogo Fujita; Hiroyasu Fujikawa; Kota Takahashi; Ota K

Collaboration


Dive into the Shogo Fujita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Teraoka

International University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Ota K

Harvard University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ichiro Nakajima

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshihiko Nakagawa

East Tennessee State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge